Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to 4.03.

  • Amphastar Pharmaceuticals' Interest Coverage Ratio fell 5269.23% to 4.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 5.93, marking a year-over-year decrease of 759.63%. This contributed to the annual value of 6.77 for FY2024, which is 666.55% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Interest Coverage Ratio is 4.03, which was down 5269.23% from 6.72 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Interest Coverage Ratio high stood at 144.36 for Q4 2021, and its period low was 4.03 during Q3 2025.
  • For the 5-year period, Amphastar Pharmaceuticals' Interest Coverage Ratio averaged around 42.04, with its median value being 10.24 (2023).
  • In the last 5 years, Amphastar Pharmaceuticals' Interest Coverage Ratio soared by 34124.45% in 2021 and then plummeted by 9336.28% in 2024.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Interest Coverage Ratio stood at 144.36 in 2021, then plummeted by 50.37% to 71.65 in 2022, then tumbled by 92.03% to 5.71 in 2023, then grew by 23.08% to 7.03 in 2024, then plummeted by 42.65% to 4.03 in 2025.
  • Its Interest Coverage Ratio was 4.03 in Q3 2025, compared to 6.72 in Q2 2025 and 5.93 in Q1 2025.